Literature DB >> 6413578

Interleukin 2 receptor expression by activated HNK-1+ granular lymphocytes: a requirement for their proliferation.

T Abo, C A Miller, C M Balch, M D Cooper.   

Abstract

A subpopulation of HNK-1+ cells was found to express interleukin 2 receptor (IL 2R) as monitored by the anti-Tac monoclonal antibody after lectin or allogeneic cell stimulation. When blood mononuclear cells were stimulated with phytohemagglutinin (PHA) or concanavalin A for 3 days, or with pokeweed mitogen or allogeneic mononuclear cells for 6 days, virtually all of the HNK-1+ cells remained as small resting lymphocytes. One-fourth of these HNK-1+ cells expressed IL 2R, however, usually within 18 hr after stimulation. Neither circulating HNK-1+ cells nor unstimulated HNK-1+ cells in short-term culture expressed IL 2R. Only the subset of HNK-1+ cells that expressed T cell surface markers, such as the sheep erythrocyte receptor and Leu-4 antigen, could be induced to express IL 2R. When long-term cultures of HNK-1+ cells were established with initial PHA stimulation and the continued presence of IL 2, a majority of the cells was found to express the IL 2R. When anti-Tac antibody was added to the long-term cultures, proliferation of the HNK-1+ cells was completely inhibited. These results suggest that entry into growth cycle by this subpopulation of HNK-1+ granular lymphocytes may require two signals: a relatively nonspecific ligand interaction with cell surface glycoprotein(s) to induce expression of IL 2R, and subsequent IL 2 interaction with these specific cell surface receptors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6413578

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Abnormal expansions of granular lymphocytes: reactive lymphocytosis or chronic leukemia? Case report and literature review.

Authors:  G Gastl; H Rumpold; D Kraft; C Gattringer; G Schuler; R Margreiter; F Schmalzl; C Huber
Journal:  Blut       Date:  1986-02

2.  In vitro production of different interferon types by cloned human NK cells.

Authors:  A Nocera; G Melioli; A Merli; F Santoro; A Zicca
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

3.  Analysis of the susceptibility of CD57 T cells to CD3-mediated apoptosis.

Authors:  N Shinomiya; Y Koike; H Koyama; E Takayama; Y Habu; M Fukasawa; S Tanuma; S Seki
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

4.  Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.

Authors:  T Hercend; J D Griffin; A Bensussan; R E Schmidt; M A Edson; A Brennan; C Murray; J F Daley; S F Schlossman; J Ritz
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

5.  Interleukin 2 receptor bearing T lymphocytes in patients with chronic liver disease.

Authors:  S Kakumu; K Yoshioka; A Fuji; H Tahara
Journal:  Gastroenterol Jpn       Date:  1988-08

6.  Antigenic stimulation regulates the level of expression of interleukin 2 receptor on human T cells.

Authors:  M E Hemler; M B Brenner; J M McLean; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

7.  Natural killer cells are present in the normal human lung but are functionally impotent.

Authors:  B W Robinson; P Pinkston; R G Crystal
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

8.  Differential Contribution of BLT1 and BLT2 to Leukotriene B4-Induced Human NK Cell Cytotoxicity and Migration.

Authors:  Meng Wang; Nermine Mostafa El-Maghraby; Sylvie Turcotte; Marek Rola-Pleszczynski; Jana Stankova
Journal:  Mediators Inflamm       Date:  2015-12-01       Impact factor: 4.711

9.  Response of resting human peripheral blood natural killer cells to interleukin 2.

Authors:  G Trinchieri; M Matsumoto-Kobayashi; S C Clark; J Seehra; L London; B Perussia
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

10.  Human T-cell leukemia virus-1-positive cell line established from a patient with small cell lung cancer.

Authors:  H Matsuzaki; H Hata; N Asou; M Yoshida; F Matsuno; M Takeya; K Yamaguchi; I Sanada; K Takatsuki
Journal:  Jpn J Cancer Res       Date:  1992-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.